CAS: 845816-02-6 - Lexatumumab
Formula:Unspecified
- Synonyms:
- Immunoglobulin G1, anti-(human cytokine receptor TRAIL-R2) (human monoclonal HGS-ETR2 heavy chain), disulfide with human monoclonal HGS-ETR2 λ-chain, dimer
- Lexatumumab
- HGS-ETR 2
- HGS 1018
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Lexatumumab REF: TM-T76815CAS: 845816-02-6 | SDS-PAGE:95% SEC-HPLC:95% | 230.00 €~917.00 € | Fri 25 Oct 24 |
 | Lexatumumab REF: 3D-CLA1148CAS: 845816-02-6 | - - - | To inquire | Mon 04 Nov 24 |
Lexatumumab
CAS:845816-02-6
Lexatumumab (GHS-ETR2), a human antibody, targets TRAILR2 for anticancer effects and apoptosis in mesothelioma.
Purity:
SDS-PAGE:95% SEC-HPLC:95%
Color and Shape:
Solid
Molecular weight:
143.6 (kDa)
Ref: TM-T76815
| 1mg | 230.00 € | ||
| 5mg | 601.00 € | ||
| 10mg | 917.00 € |
Estimated delivery in United States, on Friday 25 Oct 2024
Ref: 3D-CLA1148
| Undefined size | To inquire |
Estimated delivery in United States, on Monday 4 Nov 2024
